Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance

Vanessa M. Ferreira, Sven Plein, Timothy C. Wong, Qian Tao, Zahra Raisi-Estabragh, Supriya S. Jain, Yuchi Han, Vineeta Ojha, Jiwon Kim, More Authors

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)
15 Downloads (Pure)


Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection.

Original languageEnglish
Article number21
Pages (from-to)21
Number of pages1
JournalJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
Issue number1
Publication statusPublished - 2023


  • Cardiac complications
  • Cardiovascular magnetic resonance
  • COVID-19
  • Diagnostic criteria
  • Microinfarctions
  • Multisystem inflammatory syndrome
  • Myocardial infarction
  • Myocarditis
  • SARS-CoV-2
  • Thrombotic complications

Cite this